HB 1494 Pennsylvania House · 2025-2026 Regular Session

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, providing for over-the-counter availability of ivermectin.

HB 1494 would amend Pennsylvania's Controlled Substance Act to allow ivermectin (for human use) to be sold over-the-counter without a prescription or consultation with a healthcare provider. This change directly affects consumers who can purchase ivermectin at pharmacies or stores without needing a doctor's visit, and pharmacies that would sell it. The bill specifies that ivermectin must be "suitable for human use" to qualify as an over-the-counter medication under state law. It takes effect 60 days after enactment, making this a concrete policy shift in how the medication is distributed in Pennsylvania.
Bill status in committee 1 of 4 stages cleared
Introduction
May 2025
Committee Review
Floor Vote
Governor
Introduced May 21, 2025 Last action May 21, 2025